|
covalent chromatin modification
|
GO:0016569 |
163 |
0.529
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.360
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.285
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.263
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.227
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.225
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.223
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.218
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.214
|
|
|
smad protein complex assembly
|
GO:0007183 |
1 |
0.198
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.195
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.184
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.179
|
|
|
germline cell cycle switching mitotic to meiotic cell cycle
|
GO:0051729 |
1 |
0.178
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.157
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.153
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.132
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.130
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.124
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.121
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.116
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.107
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.105
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.101
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.101
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.097
|
|
|
histone modification
|
GO:0016570 |
159 |
0.094
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.093
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.088
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.087
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.087
|
|
|
regulation of genetic imprinting
|
GO:2000653 |
5 |
0.086
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.086
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.083
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.080
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.080
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.079
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.078
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.078
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.077
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.076
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.075
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.074
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.072
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.072
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.071
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.070
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.070
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.069
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.068
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.067
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.067
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.067
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.063
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.063
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.062
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.061
|
|
|
positive regulation of smad protein import into nucleus
|
GO:0060391 |
2 |
0.061
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.059
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.058
|
|
|
methylation
|
GO:0032259 |
134 |
0.057
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.056
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.056
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.056
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.055
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.054
|
|
|
rna processing
|
GO:0006396 |
105 |
0.054
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.052
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.052
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.052
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.052
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.052
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.052
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.051
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.050
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.050
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.050
|
|
|
regulation of peptidyl threonine phosphorylation
|
GO:0010799 |
12 |
0.050
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.049
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.049
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.049
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.048
|
|
|
liver development
|
GO:0001889 |
66 |
0.048
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.047
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.047
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.046
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.045
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.044
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.044
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.044
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.042
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.042
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.042
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.041
|
|
|
histone h3 k9 trimethylation
|
GO:0036124 |
6 |
0.041
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.041
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.041
|
|
|
endothelial cell activation
|
GO:0042118 |
1 |
0.040
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.040
|
|
|
gland development
|
GO:0048732 |
330 |
0.040
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.039
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.039
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.039
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.039
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.038
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.038
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.037
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.037
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.036
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.036
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.036
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.036
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.035
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.035
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.034
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.034
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.034
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.034
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.034
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.033
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.033
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.033
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.033
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.033
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.032
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.032
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.032
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.032
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.031
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.031
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.031
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.031
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.031
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.030
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.030
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.030
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.030
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.030
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.029
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.029
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.028
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.028
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.028
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.027
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.027
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.027
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.027
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.027
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.027
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.027
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.026
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.026
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.026
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.026
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.026
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.025
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.025
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.025
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.025
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.025
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.025
|
|
|
demethylation
|
GO:0070988 |
23 |
0.025
|
|
|
negative regulation of peptidyl threonine phosphorylation
|
GO:0010801 |
6 |
0.025
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.024
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.024
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.024
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.024
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.024
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.024
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.023
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.023
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.023
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.022
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.022
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.022
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.022
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.022
|
|
|
nephrogenic mesenchyme morphogenesis
|
GO:0072134 |
2 |
0.022
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.022
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.022
|
|
|
positive regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032436 |
23 |
0.022
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.022
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.022
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.022
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.022
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.021
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.021
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.021
|
|
|
brainstem development
|
GO:0003360 |
3 |
0.021
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.021
|
|
|
somite development
|
GO:0061053 |
81 |
0.021
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.021
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.021
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.020
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.020
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.020
|
|
|
ossification
|
GO:0001503 |
216 |
0.020
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.020
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.020
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.020
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.020
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.020
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.020
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.020
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.020
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.019
|
|
|
positive regulation of chromosome segregation
|
GO:0051984 |
4 |
0.019
|
|
|
regulation of dna demethylation
|
GO:1901535 |
2 |
0.019
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.019
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.019
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.019
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.019
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.019
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.019
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
42 |
0.018
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.018
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.018
|
|
|
renal system development
|
GO:0072001 |
225 |
0.018
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
8 |
0.018
|
|
|
osteoblast development
|
GO:0002076 |
17 |
0.018
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.018
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.018
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.018
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.018
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.018
|
|
|
amide transport
|
GO:0042886 |
138 |
0.018
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.018
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.018
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.018
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.017
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.017
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.017
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.017
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.017
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.017
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.017
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.017
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.017
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.017
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.017
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.017
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.017
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.017
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.017
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.017
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.017
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.017
|
|
|
cell growth
|
GO:0016049 |
130 |
0.017
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.017
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.017
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.017
|
|
|
wound healing
|
GO:0042060 |
157 |
0.017
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.017
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.016
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.016
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.016
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.016
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.016
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.016
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.016
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.016
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.016
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.016
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.016
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.016
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.016
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.016
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.015
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
15 |
0.015
|
|
|
placenta development
|
GO:0001890 |
140 |
0.015
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.015
|
|
|
gonad development
|
GO:0008406 |
141 |
0.015
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.015
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.015
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.015
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.015
|
|
|
mitotic chromosome condensation
|
GO:0007076 |
1 |
0.015
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.015
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.014
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.014
|
|
|
response to uv
|
GO:0009411 |
44 |
0.014
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.014
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.014
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.014
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.014
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.014
|
|
|
appendage development
|
GO:0048736 |
166 |
0.014
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.014
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.014
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.014
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.014
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.014
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.014
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.014
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.014
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.014
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.014
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
15 |
0.014
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.013
|
|
|
dna repair
|
GO:0006281 |
107 |
0.013
|
|
|
palate development
|
GO:0060021 |
76 |
0.013
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.013
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.013
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.013
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.013
|
|
|
cellular response to vitamin d
|
GO:0071305 |
2 |
0.013
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.013
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.013
|
|
|
regulation of response to alcohol
|
GO:1901419 |
2 |
0.013
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.013
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.013
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.013
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.013
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.013
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.013
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.013
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.013
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.013
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.013
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.013
|
|
|
rna polyadenylation
|
GO:0043631 |
6 |
0.013
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.013
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.013
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.012
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.012
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.012
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.012
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.012
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.012
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.012
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.012
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.012
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.012
|
|
|
regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003250 |
1 |
0.012
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.012
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.012
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
7 |
0.012
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.012
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.012
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.012
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.012
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.012
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.012
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.012
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.012
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.012
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.012
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.012
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.012
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
36 |
0.012
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.012
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.012
|
|
|
organ growth
|
GO:0035265 |
117 |
0.012
|
|
|
heart process
|
GO:0003015 |
94 |
0.012
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.012
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.012
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.012
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.011
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
40 |
0.011
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.011
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.011
|
|
|
sister chromatid segregation
|
GO:0000819 |
20 |
0.011
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.011
|
|
|
establishment or maintenance of polarity of embryonic epithelium
|
GO:0016332 |
1 |
0.011
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.011
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.011
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.011
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.011
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.011
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.011
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.011
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.011
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.011
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.011
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.011
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.011
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.011
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.011
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.011
|
|
|
skin development
|
GO:0043588 |
220 |
0.011
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.011
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.011
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.011
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.011
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.011
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
11 |
0.011
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.011
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.011
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.011
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.011
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.011
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.011
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.011
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.011
|
|
|
trophectodermal cellular morphogenesis
|
GO:0001831 |
3 |
0.011
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.011
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.011
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.011
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.010
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.010
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.010
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.010
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.010
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.010
|
|
|
regulation of cd4 positive alpha beta t cell activation
|
GO:2000514 |
24 |
0.010
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.010
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.010
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.010
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.010
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.010
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.010
|
|
|
dendritic spine organization
|
GO:0097061 |
26 |
0.010
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.010
|
|
|
negative regulation of alpha beta t cell activation
|
GO:0046636 |
18 |
0.010
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.010
|
|
|
regionalization
|
GO:0003002 |
337 |
0.010
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.010
|
|